Joint Fellowship Training Program
The National Cancer Institute (NCI), National Institutes of Health, and U.S. Food and Drug Administration (FDA), U.S. Department Health and Human Services (DHHS) are offering fellowship training for Ph.D.s, M.D.s, and M.D./Ph.D.s or their equivalents in cancer-related scientific research and research-related regulatory review.
The objective of the NCI-FDA fellowships is to train a cadre of scientists in research and research-related regulatory review, policies, and regulations so that they develop a skill set that bridge the two disparate processes. Fellows will learn to build awareness of regulatory requirements into the early stages of the medical product development process and will develop strategies to improve planning throughout research and regulatory review.
Fellows will be trained in preclinical oncology research, cancer prevention, clinical trials methodology, medical product, and other regulatory research and review. By combining training in cancer-related scientific research and research-related regulatory review, this program will help fellows learn to bridge the development and review processes. Fellows will also learn to build awareness of regulatory requirements into the early stages of medical product development and to improve planning throughout both processes. Graduates of this program will develop skills of value to academia, the pharmaceutical industry, and government agencies.
An overview of the program is available here